The average Alexion Pharmaceuticals Investor Relations in Boulder earns an estimated $83,595 annually. Alexion Pharmaceuticals' Investor Relations compensation is $1,665 more than the US average for a Investor Relations.
Last updated 2 years ago.
The majority of Investor Relations at Alexion Pharmaceuticals believe they're compensated fairly. 100% of Investor Relations at Alexion Pharmaceuticals say they receive annual bonuses, and the vast majority (71%) are satisfied with their benefits. See more compensation ratings at Alexion Pharmaceuticals